Kunwha will be responsible for the regulatory filing of BEMA Fentanyl in South Korea as well as future commercialization in that territory. The agreement results in potential milestone
Reportedly, Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting
The patent, titled ‘Molecular Property Modeling Using Ranking’, describes methods for using advanced machine-learning technology to design small molecule compounds in silico that meet specific candidate drug profiles.
Sohm said that the order contains primarily metformin, an oral anti-diabetic drug and first-line drug of choice for the treatment of type 2 diabetes and sildenafil citrate, used
Amira said that this is the second patent granted of a large estate filed by it that describe small molecule inhibitors of the DP2 (CRTH2) receptor. Amira has
Bioenergy Life Science said that Corvalen M comprises D-Ribose, a simple, 5-carbon monosaccharide, or pentose sugar. D-Ribose helps accelerate the formation of adenosine triphosphate (ATP), the primary energy
Roche has received approvals for the anti-HCV test on three platforms like the stand-alone cobas e 411 analyzer for low-volume testing and the cobas e 601 and Modular
Amgen’s Prolia has been approved in all 27 European Union (EU) member states plus Norway, Iceland and Liechtenstein. The European approval of Prolia marks the first approval of
The acquisition of Aton follows a number of recent acquisitions, including Brazil’s Instituto Terapeutico Delta, in March, and the April acquisition of an unnamed Brazilian company and Canada’s
Kemwell has decided to increase the production capacity by expanding the production area from 16,000 to 31,000 square meters. The expansion not only makes it possible for the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.